Resistance Mechanisms to Colorectal Cancer Therapeutics and the Clinical Implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resistance Mechanisms to Colorectal Cancer Therapeutics and the Clinical Implications

Published:2017-06-16 Issue:4 Volume:13 Page:334-340
ISSN:1556-3790
Container-title:Current Colorectal Cancer Reports
language:en
Short-container-title:Curr Colorectal Cancer Rep

Author:

Emmerich Philip,Clipson Linda,Deming Dustin A.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Oncology,Hepatology

Link

http://link.springer.com/article/10.1007/s11888-017-0374-5/fulltext.html

Reference59 articles.

1. Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016;7(3):105–14.

2. Laufman L, Bukowski RM, Collier MA, et al. A randomized double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer. J Clin Oncol. 1993;11(10):1888.

3. Venook A, Niedzwiecki D, Lenz HJ, et al. CALGB/SWOG 80405: phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). J Clin Oncol. 2017;32:5s (suppl; abstr LBA3).

4. Heidelberger C, Chaudhuri NK, Danenberg PV, et al. Fluorinated pyrimidines: a new class of tumor inhibitory compounds. Nature. 1957;179:663.

5. de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol. 1997;15(2):808.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of pectins on colorectal cancer: targeting hallmarks as a support for future clinical trials;Food & Function;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3